216 related articles for article (PubMed ID: 35635079)
1. Dexmedetomidine protects H9C2 rat cardiomyocytes against hypoxia/reoxygenation injury by regulating the long non-coding RNA colon cancer-associated transcript 1/microRNA-8063/Wnt/β-catenin axis.
Liu C; Xu R
Bioengineered; 2022 May; 13(5):13300-13311. PubMed ID: 35635079
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.
Wang Z; Yang Y; Xiong W; Zhou R; Song N; Liu L; Qian J
Biomed Pharmacother; 2020 May; 125():110001. PubMed ID: 32070878
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of miR-148b ameliorates myocardial ischemia/reperfusion injury via regulation of Wnt/β-catenin signaling pathway.
Yang M; Kong DY; Chen JC
J Cell Physiol; 2019 Aug; 234(10):17757-17766. PubMed ID: 30820984
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine protects hepatic cells against oxygen-glucose deprivation/reperfusion injury via lncRNA CCAT1.
Zhou Z; Chen Q; Wan L; Zheng D; Li Z; Wu Z
Cell Biol Int; 2018 Sep; 42(9):1250-1258. PubMed ID: 29851220
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA TALNEC2 regulates myocardial ischemic injury in H9c2 cells by regulating miR-21/PDCD4-medited activation of Wnt/β-catenin pathway.
Hao L; Wang J; Liu N
J Cell Biochem; 2019 Aug; 120(8):12912-12923. PubMed ID: 30861181
[TBL] [Abstract][Full Text] [Related]
6. LncRNA AZIN1-AS1 ameliorates myocardial ischemia-reperfusion injury by targeting miR-6838-5p/WNT3A axis to activate Wnt-β/catenin signaling pathway.
Zhang G; Ding L; Sun G; Liu Z; Ou W; Wang B; Sun Y
In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):54-68. PubMed ID: 35064471
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.
Wang L; Liu J; Wang Z; Qian X; Zhao Y; Wang Q; Dai N; Xie Y; Zeng W; Yang W; Bai X; Yang Y; Qian J
Biomed Pharmacother; 2023 Sep; 165():115255. PubMed ID: 37549462
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA FTX alleviates hypoxia/reoxygenation-induced cardiomyocyte injury via miR-410-3p/Fmr1 axis.
Li L; Li L; Zhang YZ; Yang HY; Wang YY
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):396-408. PubMed ID: 31957854
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA Taurine-Upregulated Gene 1 Knockdown Protects Cardiomyocytes Against Hypoxia/Reoxygenation-induced Injury Through Regulating miR-532-5p/Sox8 Axis.
Cai X; Wang S; Hong L; Yu S; Li B; Zeng H; Yang X; Zhang P; Shao L
J Cardiovasc Pharmacol; 2020 Nov; 76(5):556-563. PubMed ID: 32833900
[TBL] [Abstract][Full Text] [Related]
10. The lncRNA, H19 Mediates the Protective Effect of Hypoxia Postconditioning Against Hypoxia-Reoxygenation Injury to Senescent Cardiomyocytes by Targeting microRNA-29b-3p.
Zhang X; Cheng L; Xu L; Zhang Y; Yang Y; Fu Q; Mi W; Li H
Shock; 2019 Aug; 52(2):249-256. PubMed ID: 29958242
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long noncoding RNA MIAT attenuates hypoxia-induced cardiomyocyte injury by regulating the miR-488-3p/Wnt/β-catenin pathway.
Zhang M; Zhang Z; Hu J; Zhou S; Ai W
Cell Biol Int; 2023 Jan; 47(1):63-74. PubMed ID: 36273414
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway.
Chu Y; Teng J; Feng P; Liu H; Wang F; Wang H
Pharmacology; 2022; 107(1-2):14-27. PubMed ID: 34718238
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine-mediated regulation of miR-17-3p in H9C2 cells after hypoxia/reoxygenation injury.
Yuan T; Yang Z; Xian S; Chen Y; Wang L; Chen W; Long W; Che Y
Exp Ther Med; 2020 Aug; 20(2):917-925. PubMed ID: 32742334
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.
Yuan M; Meng XW; Ma J; Liu H; Song SY; Chen QC; Liu HY; Zhang J; Song N; Ji FH; Peng K
Drug Des Devel Ther; 2019; 13():3137-3149. PubMed ID: 31564830
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA ROR sponges miR-138 to aggravate hypoxia/reoxygenation-induced cardiomyocyte apoptosis via upregulating Mst1.
Hu YH; Sun J; Zhang J; Hua FZ; Liu Q; Liang YP
Exp Mol Pathol; 2020 Jun; 114():104430. PubMed ID: 32240614
[TBL] [Abstract][Full Text] [Related]
16. MiR-26a-5p Targets WNT5A to Protect Cardiomyocytes from Injury Due to Hypoxia/Reoxygenation Through the Wnt/β-catenin Signaling Pathway.
Yan G; Wang J; Fang Z; Yan S; Zhang Y
Int Heart J; 2021 Sep; 62(5):1145-1152. PubMed ID: 34544974
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of lncRNA ZFAS1 protects H9c2 cardiomyocytes from ischemia/reperfusion‑induced apoptosis via the miR‑590‑3p/NF‑κB signaling pathway.
Huang P; Yang D; Yu L; Shi Y
Mol Med Rep; 2020 Sep; 22(3):2300-2306. PubMed ID: 32705215
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms.
Cai S; Liu Y; Cheng Y; Yuan J; Fang J
J Clin Lab Anal; 2022 Jul; 36(7):e24119. PubMed ID: 34882841
[TBL] [Abstract][Full Text] [Related]
19. Propofol protects cardiomyocytes from hypoxia/reoxygenation injury via regulating MALAT1/miR-206/ATG3 axis.
Jing H; Wang C; Zhao L; Cheng J; Qin P; Lin H
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22880. PubMed ID: 34383354
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
